James Pellicane

848 total citations
21 papers, 520 citations indexed

About

James Pellicane is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, James Pellicane has authored 21 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 8 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in James Pellicane's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (5 papers). James Pellicane is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (5 papers). James Pellicane collaborates with scholars based in United States, Switzerland and Sweden. James Pellicane's co-authors include Eric J. DeMaria, Karl Byrne, Pat W. Whitworth, Peter D. Beitsch, Lisette Stork‐Sloots, Femke A. de Snoo, J. David Beatty, Paul L. Baron, Mary K. Murray and Laura A. Lee and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

James Pellicane

19 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Pellicane United States 12 224 184 147 78 75 21 520
Jiro Shimazaki Japan 13 88 0.4× 289 1.6× 260 1.8× 134 1.7× 43 0.6× 41 683
Jeremy D. Hayden United Kingdom 16 81 0.4× 488 2.7× 115 0.8× 293 3.8× 109 1.5× 37 696
William Williard United States 12 71 0.3× 293 1.6× 144 1.0× 130 1.7× 127 1.7× 14 517
Srujitha Murukutla United States 5 134 0.6× 103 0.6× 401 2.7× 99 1.3× 19 0.3× 15 531
T Kono Japan 13 41 0.2× 211 1.1× 134 0.9× 61 0.8× 45 0.6× 36 600
E Procaccini Italy 10 88 0.4× 188 1.0× 161 1.1× 91 1.2× 46 0.6× 25 433
Deepak Thomas Abraham India 14 92 0.4× 346 1.9× 88 0.6× 68 0.9× 46 0.6× 63 661
Gizem Akkaş Türkiye 11 95 0.4× 303 1.6× 469 3.2× 117 1.5× 27 0.4× 24 629
Nirmal K. Veeramachaneni United States 14 119 0.5× 189 1.0× 167 1.1× 546 7.0× 26 0.3× 37 821
Tetsuro Ikeya Japan 12 178 0.8× 172 0.9× 479 3.3× 111 1.4× 23 0.3× 20 640

Countries citing papers authored by James Pellicane

Since Specialization
Citations

This map shows the geographic impact of James Pellicane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Pellicane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Pellicane more than expected).

Fields of papers citing papers by James Pellicane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Pellicane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Pellicane. The network helps show where James Pellicane may publish in the future.

Co-authorship network of co-authors of James Pellicane

This figure shows the co-authorship network connecting the top 25 collaborators of James Pellicane. A scholar is included among the top collaborators of James Pellicane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Pellicane. James Pellicane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beitsch, Peter D., James Pellicane, Lajos Pusztai, et al.. (2023). MammaPrint Index as a predictive biomarker for neoadjuvant chemotherapy response and outcome in patients with HR+HER2- breast cancer in NBRST.. Journal of Clinical Oncology. 41(16_suppl). 521–521. 3 indexed citations
2.
Whitworth, Pat W., James Pellicane, Paul L. Baron, et al.. (2021). Abstract PD9-01: 5-year outcomes in the NBRST trial: Preoperative MammaPrint and BluePrint breast cancer subtype is associated with neoadjuvant treatment response and survival. Cancer Research. 81(4_Supplement). PD9–1. 3 indexed citations
3.
Weinmann, Sheila, Michael C. Leo, Melanie Francisco, et al.. (2020). Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy. Clinical Cancer Research. 26(15). 4054–4063. 34 indexed citations
4.
Beitsch, Peter D., Pat W. Whitworth, Paul L. Baron, et al.. (2017). Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). Annals of Surgical Oncology. 24(9). 2539–2546. 28 indexed citations
5.
Bremer, Troy, Pat W. Whitworth, Todd Barry, et al.. (2017). Abstract S5-01: DCIS biological risk profile predicts risk of recurrence after breast conserving surgery in a Kaiser Permanente NW population. Cancer Research. 77(4_Supplement). S5–1. 1 indexed citations
6.
Beitsch, Peter D., et al.. (2016). Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures. Annals of Surgical Oncology. 23(10). 3317–3323. 11 indexed citations
7.
Whitworth, Pat W., Peter D. Beitsch, James Pellicane, et al.. (2016). Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping. Annals of Surgical Oncology. 24(3). 669–675. 63 indexed citations
8.
Pellicane, James, et al.. (2016). Surgical Delay of the Nipple–Areolar Complex in High-risk Nipple-sparing Mastectomy Reconstruction. Plastic & Reconstructive Surgery Global Open. 4(6). e760–e760. 19 indexed citations
9.
Baron, Paul L., Peter D. Beitsch, Danielle Boselli, et al.. (2015). Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 23(5). 1522–1529. 24 indexed citations
10.
Whitworth, Pat W., Peter D. Beitsch, James Pellicane, et al.. (2015). Functional subtyping with BluePrint 80-gene profile to identify distinct triple-positive subtypes with and without trastuzumab/chemosensitivity.. Journal of Clinical Oncology. 33(28_suppl). 114–114.
11.
Whitworth, Pat W., Lisette Stork‐Sloots, Femke A. de Snoo, et al.. (2014). Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). Annals of Surgical Oncology. 21(10). 3261–3267. 52 indexed citations
12.
Pellicane, James. (2013). Genomic Testing for Breast Cancer. Oncology Issues. 28(6). 42–47.
13.
14.
Fine, Richard E., et al.. (2009). A novel ultrasound-guided electrosurgical loop device for intra-operative excision of breast lesions; an improvement in surgical technique. The American Journal of Surgery. 198(2). 283–286. 4 indexed citations
15.
Pellicane, James, et al.. (1997). Meckel's diverticulum: a ten-year experience.. PubMed. 63(4). 354–5. 75 indexed citations
16.
Pellicane, James, et al.. (1997). Nonocclusive intestinal ischemia: improved outcome with early diagnosis and therapy.. PubMed. 63(4). 334–7. 5 indexed citations
17.
Pellicane, James, Dennis C. Gore, & Eric J. DeMaria. (1994). Decreased Lactate in Endotoxin-Resistant Mice Undergoing Hemorrhage Is Independent of Tumor Necrosis Factor Availability. Journal of Surgical Research. 56(4). 361–366. 5 indexed citations
18.
Bettinger, David A., et al.. (1994). THE ROLE OF INFLAMMATORY CYTOKINES IN WOUND HEALING. The Journal of Trauma: Injury, Infection, and Critical Care. 36(6). 810–814. 53 indexed citations
19.
Pellicane, James, Karl Byrne, & Eric J. DeMaria. (1992). PREVENTABLE COMPLICATIONS AND DEATH FROM MULTIPLE ORGAN FAILURE AMONG GERIATRIC TRAUMA VICTIMS. The Journal of Trauma: Injury, Infection, and Critical Care. 33(3). 440–444. 65 indexed citations
20.
DeMaria, Eric J., et al.. (1992). HEMORRHAGIC SHOCK IN ENDCTOXIN RESISTANT MICE. The Journal of Trauma: Injury, Infection, and Critical Care. 33(1). 151–151. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiro Shimazaki Breakdown of academic impact, for papers by Jeremy D. Hayden Breakdown of academic impact, for papers by William Williard Breakdown of academic impact, for papers by Srujitha Murukutla Breakdown of academic impact, for papers by T Kono Breakdown of academic impact, for papers by E Procaccini Breakdown of academic impact, for papers by Deepak Thomas Abraham Breakdown of academic impact, for papers by Gizem Akkaş Breakdown of academic impact, for papers by Nirmal K. Veeramachaneni Breakdown of academic impact, for papers by Tetsuro Ikeya
Rankless by CCL
2026